Dermatopathic lymphadenopathy after COVID-19 vaccination

Pathology. 2024 Aug;56(5):740-742. doi: 10.1016/j.pathol.2024.01.005. Epub 2024 Mar 26.

Authors

Jie-Yang Jhuang¹, Yen-Chieh Chen², Yung-Fang Chia³, Shih-Sung Chuang⁴

Affiliations

¹ Department of Pathology, Mackay Memorial Hospital, Tamsui Branch, New Taipei City, Taiwan.
² Department of Surgery, Miaoli General Hospital, Ministry of Health and Welfare, Miaoli, Taiwan.
³ Department of Pathology, Miaoli General Hospital, Ministry of Health and Welfare, Miaoli, Taiwan.
⁴ Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan. Electronic address: cmh5301@mail.chimei.org.tw.

PMID: 38599961
DOI: 10.1016/j.pathol.2024.01.005

No abstract available

Publication types

Case Reports
Letter

MeSH terms

COVID-19 Vaccines* / adverse effects
COVID-19* / complications
COVID-19* / prevention & control
Humans
Lymphadenopathy* / chemically induced
Lymphadenopathy* / etiology
Lymphadenopathy* / pathology
Middle Aged
SARS-CoV-2
Vaccination / adverse effects

Substances

COVID-19 Vaccines